Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track CNTB with free AI briefings, catalyst countdowns, and dilution alerts.

CNTB · Connect Biopharma Holdings Limi

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$45M Cash, Jun 2026

8mo Cash Runway (est.)

+13% Share Count, 1 Year

Follow CNTB by email Get an email when CNTB pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about CNTB, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

CNTB reported $45M in cash and short-term investments (as of Jun 30, 2026) and used about $16.1M/quarter in operations, an estimated runway of 8.4 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 62 · High

Cash runway 8 months +30
ATM program on file since Jun 2025 +15
Shelf registration (F-3, Jun 2025) +10
Share count +13% in a year +7

Recent financing filings on SEC EDGAR:

Mar 30, 2026 · Private placement (8-K Item 3.02) · 8-K
Jun 10, 2025 · Shelf registration with ATM program, up to $150M · F-3

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when CNTB files for a raise →

Get the full CNTB picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CNTB and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z